Australia

Back to map

Showing 11-20 of 28 grants

Title Institution Researcher Program Duration Total Award Amount
A simple assay to monitor autoimmune T cell responses in T1D St. Vincent's Institute of Medical Research Stuart Mannering Cures 01-November-2024 to 31-October-2025 $122,849.00
A synergistic approach to preventing islet allograft rejection in beta cell replacement therapy St. Vincent's Institute of Medical Research Seigmund Lai Cures 01-March-2025 to 29-February-2028 $256,285.00
A simple, whole blood assay for beta cell autoimmunity St. Vincent's Institute of Medical Research Matthew Lacorcia Cures 01-March-2024 to 28-February-2027 $235,025.00
Using JAK inhibitors with locally delivered immunosuppression to target islet graft rejection St. Vincent's Institute of Medical Research Helen Thomas Cures 01-July-2022 to 30-June-2024 $500,000.00
Finding T1D driver genes: Targets for future therapies The University of Adelaide Ying Wong Cures 01-March-2024 to 28-February-2027 $267,920.00
Using Multi-omics to turn islet autoimmunity driver genes into therapies The University of Adelaide Simon Barry Cures 01-August-2024 to 31-July-2027 $446,624.00
Expanded data mining of accumulated functional genomics data for identifying mechanistic biomarkers informative of T1D risk and prevention The University of Adelaide Megan Penno Cures 01-June-2024 to 31-May-2027 $444,306.96
Investigating the utility of urine C-peptide in early-stage T1D The University of Adelaide Jennifer Couper Cures 01-September-2024 to 31-August-2025 $93,760.34
Experiences of children with early-stage T1D and their families in three Australian monitoring cohorts: what matters most for engagement in a national program? The University of Adelaide Jennifer Couper Cures 01-February-2025 to 31-January-2027 $179,817.84
Improving Glucose Levels while Preventing Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor (PARTNER) The University of Melbourne David O'Neal Improving Lives 01-November-2024 to 31-October-2026 $221,126.00